EUVIMEDOpdag EUVIMED
Crossref

Efficacy and tolerability of 1 L polyethylene glycol plus ascorbic acid with senna versus 2 L polyethylene glycol plus ascorbic acid for colonoscopic bowel preparation: Prospective, randomized, investigator‐blinded trial

Natsumi Maeda, Akira Higashimori, Masami Nakatani, Kagami Jinnai, Daiyu Kin, Naoko Sugita, Kenichi Morimoto, Eiji Sasaki, Takashi Fukuda, Yasuhiro Fujiwara

Digestive Endoscopy · 2023

DOI: 10.1111/den.14504 ↗

At a glance

Journal article in Digestive Endoscopy, 2023. Written by Natsumi Maeda and 9 co-authors. Institution: Department of Gastroenterology, Minami Osaka Hospital, Osaka, Japan. Major MEDLINE topics: Polyethylene Glycols, Ascorbic Acid. Cited 8 times so far (Crossref); 47 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objectives

Low‐volume polyethylene glycol plus ascorbic acid (PEG‐Asc) reduces the dosage of colonoscopic bowel preparation (BP) solution, but is still poorly tolerated. Adding laxatives to the BP solution reduces the volume of fluid required, without affecting quality. This study aimed to compare 1 L PEG‐Asc plus 24 mg senna (1L‐PEG/AS) and conventional 2 L PEG‐Asc (2L‐PEG/A) regimens on BP quality and patient tolerability.

Methods

A single‐center, randomized, investigator‐blinded, noninferiority trial was performed between June and August 2022. Outpatients scheduled for colonoscopy were randomized (1:1) to the 1L‐PEG/AS or 2L‐PEG/A group. The Boston Bowel Preparation Scale (BBPS) was used to evaluate BP quality. Adverse events and tolerability were surveyed using questionnaires.

Results

Overall, 344 patients received 1L‐PEG/AS or 2L‐PEG/A regimens. The baseline characteristics and adverse events of the two groups were comparable. The 1L‐PEG/AS group showed noninferior adequate BP rates compared with the 2L‐PEG/A group (88% vs. 89%, P = 1.00); overall BBPS was 7.1 ± 1.5 and 7.2 ± 1.5, respectively ( P = 0.39). Higher willingness to repeat the BP was observed in the 1L‐PEG/AS group (85% vs. 62%, P < 0.01).

Conclusions

The 1L‐PEG/AS regimen was comparable to the 2L‐PEG/A regimen in terms of BP adequacy, requiring lower BP solution volumes, with better patient tolerance. Thus, it may be a suitable alternative to the conventional BP solution for colonoscopy. The Japan Registry of Clinical Trials (jRCT1051220043).

Subjects

MeSH terms (MEDLINE)

Polyethylene GlycolsAscorbic AcidHumansProspective StudiesCatharticsSennosidesColonoscopy

Author keywords

Boston Bowel Preparation Scalebowel preparationcolonoscopypolyethylene glycol plus ascorbic acidsenna

Substances

Polyethylene GlycolsAscorbic AcidCatharticsSennosides

Authors and institutions

  • Department of Gastroenterology, Minami Osaka Hospital, Osaka, Japan.
  • Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

Cite

APA

Maeda, N., Higashimori, A., Nakatani, M., Jinnai, K., Kin, D., Sugita, N., Morimoto, K., Sasaki, E., Fukuda, T., & Fujiwara, Y. (2023). Efficacy and tolerability of 1 L polyethylene glycol plus ascorbic acid with senna versus 2 L polyethylene glycol plus ascorbic acid for colonoscopic bowel preparation: Prospective, randomized, investigator‐blinded trial. Digestive Endoscopy. https://doi.org/10.1111/den.14504

Vancouver

Maeda N, Higashimori A, Nakatani M, Jinnai K, Kin D, Sugita N, et al. Efficacy and tolerability of 1 L polyethylene glycol plus ascorbic acid with senna versus 2 L polyethylene glycol plus ascorbic acid for colonoscopic bowel preparation: Prospective, randomized, investigator‐blinded trial. Digestive Endoscopy. 2023. doi:10.1111/den.14504

BibTeX
@article{Maeda2023,
  author = {Maeda, Natsumi and Higashimori, Akira and Nakatani, Masami and Jinnai, Kagami and Kin, Daiyu and Sugita, Naoko and Morimoto, Kenichi and Sasaki, Eiji and Fukuda, Takashi and Fujiwara, Yasuhiro},
  title = {Efficacy and tolerability of 1 L polyethylene glycol plus ascorbic acid with senna versus 2 L polyethylene glycol plus ascorbic acid for colonoscopic bowel preparation: Prospective, randomized, investigator‐blinded trial},
  journal = {Digestive Endoscopy},
  year = {2023},
  doi = {10.1111/den.14504}
}
Start for free →